vs
Side-by-side financial comparison of Lucid Diagnostics Inc. (LUCD) and Picard Medical, Inc. (PMI). Click either name above to swap in a different company.
Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $1.2M, roughly 1.0× Picard Medical, Inc.). Lucid Diagnostics Inc. runs the higher net margin — -858.5% vs -878.3%, a 19.8% gap on every dollar of revenue.
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.
LUCD vs PMI — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.2M |
| Net Profit | $-10.4M | $-10.4M |
| Gross Margin | — | -11.0% |
| Operating Margin | -971.0% | -293.8% |
| Net Margin | -858.5% | -878.3% |
| Revenue YoY | 3.3% | — |
| Net Profit YoY | 16.0% | — |
| EPS (diluted) | $-0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $1.2M | $1.2M | ||
| Q2 25 | $1.2M | $2.1M | ||
| Q1 25 | $828.0K | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $1.2M | — | ||
| Q2 24 | $976.0K | — | ||
| Q1 24 | $1.0M | — | ||
| Q4 23 | $1.0M | — |
| Q3 25 | $-10.4M | $-10.4M | ||
| Q2 25 | $-4.4M | $-6.7M | ||
| Q1 25 | $-26.9M | — | ||
| Q4 24 | $-11.5M | — | ||
| Q3 24 | $-12.4M | — | ||
| Q2 24 | $-11.0M | — | ||
| Q1 24 | $-10.6M | — | ||
| Q4 23 | $-10.8M | — |
| Q3 25 | — | -11.0% | ||
| Q2 25 | — | -6.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q3 25 | -971.0% | -293.8% | ||
| Q2 25 | -978.8% | -165.2% | ||
| Q1 25 | -1508.1% | — | ||
| Q4 24 | -1033.8% | — | ||
| Q3 24 | -997.8% | — | ||
| Q2 24 | -1146.7% | — | ||
| Q1 24 | -1078.1% | — | ||
| Q4 23 | -1101.3% | — |
| Q3 25 | -858.5% | -878.3% | ||
| Q2 25 | -381.7% | -315.5% | ||
| Q1 25 | -3249.8% | — | ||
| Q4 24 | -964.2% | — | ||
| Q3 24 | -1055.5% | — | ||
| Q2 24 | -1127.6% | — | ||
| Q1 24 | -1060.1% | — | ||
| Q4 23 | -1041.3% | — |
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $-0.08 | — | ||
| Q1 25 | $-0.52 | — | ||
| Q4 24 | $-0.17 | — | ||
| Q3 24 | $-0.25 | — | ||
| Q2 24 | $-0.23 | — | ||
| Q1 24 | $-0.40 | — | ||
| Q4 23 | $-0.25 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.3M | $2.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $25.8M | $8.0M |
| Total Assets | $53.2M | $13.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $47.3M | $2.8M | ||
| Q2 25 | $31.1M | $410.0K | ||
| Q1 25 | $25.2M | — | ||
| Q4 24 | $22.4M | — | ||
| Q3 24 | $14.5M | — | ||
| Q2 24 | $24.9M | — | ||
| Q1 24 | $24.8M | — | ||
| Q4 23 | $18.9M | — |
| Q3 25 | $25.8M | $8.0M | ||
| Q2 25 | $7.9M | $-54.5M | ||
| Q1 25 | $-5.4M | — | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $11.9M | — | ||
| Q4 23 | $-2.3M | — |
| Q3 25 | $53.2M | $13.5M | ||
| Q2 25 | $38.7M | $11.7M | ||
| Q1 25 | $32.8M | — | ||
| Q4 24 | $30.7M | — | ||
| Q3 24 | $22.6M | — | ||
| Q2 24 | $34.1M | — | ||
| Q1 24 | $32.0M | — | ||
| Q4 23 | $27.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.9M | $-6.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-10.9M | $-6.5M | ||
| Q2 25 | $-10.5M | $-4.8M | ||
| Q1 25 | $-12.5M | — | ||
| Q4 24 | $-9.9M | — | ||
| Q3 24 | $-10.2M | — | ||
| Q2 24 | $-11.5M | — | ||
| Q1 24 | $-12.6M | — | ||
| Q4 23 | $-10.0M | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LUCD
Segment breakdown not available.
PMI
| Products | $1.1M | 94% |
| Other | $72.0K | 6% |
